Assessment of interobserver variability in Gleason grading for prostate carcinoma

The Gleason Score is the most widely used grading system for prostate adenocarcinoma and it is the strongest predictor of the patient's clinical outcome similar to other grading systems, and plays a key role in determining the most effective treatment strategy for the patient. The Gleason scori...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Northern Clinics of Istanbul Ročník 12; číslo 3; s. 337 - 343
Hlavný autor: Cinar, Ilkay
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Turkey KARE Publishing 01.01.2025
Kare Publishing
Predmet:
ISSN:2148-4902, 2536-4553, 2148-4902, 2536-4553
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract The Gleason Score is the most widely used grading system for prostate adenocarcinoma and it is the strongest predictor of the patient's clinical outcome similar to other grading systems, and plays a key role in determining the most effective treatment strategy for the patient. The Gleason scoring system is subject to both intraobserver and interobserver variability. This study aims to assess the interobserver agreement for prostate adenocarcinoma within the Gleason grading system at our center, as well as identify contributing factors. A total of 119 cases diagnosed with prostatic adenocarcinoma at Giresun Training and Research Hospital were included in the study. Tissue samples from the cases had been subjected to routine laboratory procedures; three-micron sections were obtained from formalin-fixed paraffin blocks and stained H&E. Statistical investigation was conducted on the agreement between Gleason pattern, Gleason sum score, and grade group data among three observers. In the evaluation, interobserver agreement was found to be minimal (Gleason pattern k=0.285, total Gleason sum score k=0.309, Grade group k=0.313). The assessment indicated higher agreement in determining low grade compared to high grade, with a decrease in interobserver agreement as the grade increased. Moreover, interobserver agreement demonstrated an increase over the years (p<0.001). The findings underscore the ongoing inadequacy of interobserver agreement in the Gleason scoring system. Improvement suggestions involve conducting studies to ascertain in-clinic interobserver agreement enhancing training, facilitating information sharing, and employing accessible and easily applicable artificial intelligence-supported programs.
AbstractList OBJECTIVE: The Gleason Score is the most widely used grading system for prostate adenocarcinoma and it is the strongest predictor of the patient's clinical outcome similar to other grading systems, and plays a key role in determining the most effective treatment strategy for the patient. The Gleason scoring system is subject to both intraobserver and interobserver variability. This study aims to assess the interobserver agreement for prostate adenocarcinoma within the Gleason grading system at our center, as well as identify contributing factors. METHODS: A total of 119 cases diagnosed with prostatic adenocarcinoma at Giresun Training and Research Hospital were included in the study. Tissue samples from the cases had been subjected to routine laboratory procedures; three-micron sections were obtained from formalin-fixed paraffin blocks and stained H&E. Statistical investigation was conducted on the agreement between Gleason pattern, Gleason sum score, and grade group data among three observers. RESULTS: In the evaluation, interobserver agreement was found to be minimal (Gleason pattern k=0.285, total Gleason sum score k=0.309, Grade group k=0.313). The assessment indicated higher agreement in determining low grade compared to high grade, with a decrease in interobserver agreement as the grade increased. Moreover, interobserver agreement demonstrated an increase over the years (p<0.001). CONCLUSION: The findings underscore the ongoing inadequacy of interobserver agreement in the Gleason scoring system. Improvement suggestions involve conducting studies to ascertain in-clinic interobserver agreement enhancing training, facilitating information sharing, and employing accessible and easily applicable artificial intelligence-supported programs. Keywords: Gleason score; interobserver agreement; prostate adenocarcinoma.
The Gleason Score is the most widely used grading system for prostate adenocarcinoma and it is the strongest predictor of the patient's clinical outcome similar to other grading systems, and plays a key role in determining the most effective treatment strategy for the patient. The Gleason scoring system is subject to both intraobserver and interobserver variability. This study aims to assess the interobserver agreement for prostate adenocarcinoma within the Gleason grading system at our center, as well as identify contributing factors.OBJECTIVEThe Gleason Score is the most widely used grading system for prostate adenocarcinoma and it is the strongest predictor of the patient's clinical outcome similar to other grading systems, and plays a key role in determining the most effective treatment strategy for the patient. The Gleason scoring system is subject to both intraobserver and interobserver variability. This study aims to assess the interobserver agreement for prostate adenocarcinoma within the Gleason grading system at our center, as well as identify contributing factors.A total of 119 cases diagnosed with prostatic adenocarcinoma at Giresun Training and Research Hospital were included in the study. Tissue samples from the cases had been subjected to routine laboratory procedures; three-micron sections were obtained from formalin-fixed paraffin blocks and stained H&E. Statistical investigation was conducted on the agreement between Gleason pattern, Gleason sum score, and grade group data among three observers.METHODSA total of 119 cases diagnosed with prostatic adenocarcinoma at Giresun Training and Research Hospital were included in the study. Tissue samples from the cases had been subjected to routine laboratory procedures; three-micron sections were obtained from formalin-fixed paraffin blocks and stained H&E. Statistical investigation was conducted on the agreement between Gleason pattern, Gleason sum score, and grade group data among three observers.In the evaluation, interobserver agreement was found to be minimal (Gleason pattern k=0.285, total Gleason sum score k=0.309, Grade group k=0.313). The assessment indicated higher agreement in determining low grade compared to high grade, with a decrease in interobserver agreement as the grade increased. Moreover, interobserver agreement demonstrated an increase over the years (p<0.001).RESULTSIn the evaluation, interobserver agreement was found to be minimal (Gleason pattern k=0.285, total Gleason sum score k=0.309, Grade group k=0.313). The assessment indicated higher agreement in determining low grade compared to high grade, with a decrease in interobserver agreement as the grade increased. Moreover, interobserver agreement demonstrated an increase over the years (p<0.001).The findings underscore the ongoing inadequacy of interobserver agreement in the Gleason scoring system. Improvement suggestions involve conducting studies to ascertain in-clinic interobserver agreement enhancing training, facilitating information sharing, and employing accessible and easily applicable artificial intelligence-supported programs.CONCLUSIONThe findings underscore the ongoing inadequacy of interobserver agreement in the Gleason scoring system. Improvement suggestions involve conducting studies to ascertain in-clinic interobserver agreement enhancing training, facilitating information sharing, and employing accessible and easily applicable artificial intelligence-supported programs.
The Gleason Score is the most widely used grading system for prostate adenocarcinoma and it is the strongest predictor of the patient's clinical outcome similar to other grading systems, and plays a key role in determining the most effective treatment strategy for the patient. The Gleason scoring system is subject to both intraobserver and interobserver variability. This study aims to assess the interobserver agreement for prostate adenocarcinoma within the Gleason grading system at our center, as well as identify contributing factors. A total of 119 cases diagnosed with prostatic adenocarcinoma at Giresun Training and Research Hospital were included in the study. Tissue samples from the cases had been subjected to routine laboratory procedures; three-micron sections were obtained from formalin-fixed paraffin blocks and stained H&E. Statistical investigation was conducted on the agreement between Gleason pattern, Gleason sum score, and grade group data among three observers. In the evaluation, interobserver agreement was found to be minimal (Gleason pattern k=0.285, total Gleason sum score k=0.309, Grade group k=0.313). The assessment indicated higher agreement in determining low grade compared to high grade, with a decrease in interobserver agreement as the grade increased. Moreover, interobserver agreement demonstrated an increase over the years (p<0.001). The findings underscore the ongoing inadequacy of interobserver agreement in the Gleason scoring system. Improvement suggestions involve conducting studies to ascertain in-clinic interobserver agreement enhancing training, facilitating information sharing, and employing accessible and easily applicable artificial intelligence-supported programs.
Author Cinar, Ilkay
Author_xml – sequence: 1
  givenname: Ilkay
  surname: Cinar
  fullname: Cinar, Ilkay
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40843333$$D View this record in MEDLINE/PubMed
BookMark eNptkk1LJDEQhoMo6rqe9yYNXrzMmI9Kd-Ykg6zugiALu-dQna4es3QnY9Iz4L_f6KgobHJISD31UpV6v7D9EAMx9k3wuYAG4DI4P5dc6rkQoOs9diwFmBksuNz_cD9ipzn_5ZxLsxC11ofsCLgBVdYx-7XMmXIeKUxV7CsfJkqxzZS2lKotJo-tH_z0VCLV7UCYY6hWCTsfVlUfU7VOMU84UeUwOR_iiF_ZQY9DptPX84T9ufn--_rH7O7-9uf18m7mQDTTrCddm1o4IK47SSixIWidAjBCdEaRQ6dRKSddC9TVWkrstMJSdyuF6NUJu9rprjftSJ0rHSQc7Dr5EdOTjejt50jwD3YVt1ZIVWtoZFG4eFVI8XFDebKjz46GAQPFTbZKQq24XtSLgp7v0BUOZH3oY5F0z7hdGmgao8CoQs3_Q5Xd0ehdGV7vy_unhLOPPbwX_zafAlzuAFf-OSfq3xHB7YsJbDGBfTaBfTGB-gd8p6TL
ContentType Journal Article
Copyright COPYRIGHT 2025 KARE Publishing
Copyright_xml – notice: COPYRIGHT 2025 KARE Publishing
DBID AAYXX
CITATION
NPM
7X8
5PM
DOI 10.14744/nci.2025.11456
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2148-4902
2536-4553
EndPage 343
ExternalDocumentID PMC12365472
A847783483
40843333
10_14744_nci_2025_11456
Genre Journal Article
GroupedDBID 7X7
8FI
8FJ
AAYXX
ABUWG
ADBBV
AFFHD
AFKRA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BCNDV
BENPR
CCPQU
CITATION
EN8
FYUFA
GROUPED_DOAJ
HMCUK
IAO
IHR
INH
ITC
M48
OK1
PHGZM
PHGZT
PIMPY
SW3
UKHRP
ADRAZ
HYE
NPM
PGMZT
RPM
7X8
5PM
ID FETCH-LOGICAL-c417t-fe56861c4e05d2ea2a7e4bc344811d83ecac5a33c2cb4ed6522ad53a433b211f3
ISICitedReferencesCount 0
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001523543000010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2148-4902
2536-4553
IngestDate Tue Nov 04 02:04:10 EST 2025
Thu Sep 04 12:30:19 EDT 2025
Tue Nov 11 10:48:59 EST 2025
Tue Nov 04 18:12:28 EST 2025
Mon Sep 15 01:50:51 EDT 2025
Sat Nov 29 07:51:17 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Gleason score
prostate adenocarcinoma
interobserver agreement
Language English
License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0)
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c417t-fe56861c4e05d2ea2a7e4bc344811d83ecac5a33c2cb4ed6522ad53a433b211f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC12365472
PMID 40843333
PQID 3246305969
PQPubID 23479
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_12365472
proquest_miscellaneous_3246305969
gale_infotracmisc_A847783483
gale_infotracacademiconefile_A847783483
pubmed_primary_40843333
crossref_primary_10_14744_nci_2025_11456
PublicationCentury 2000
PublicationDate 2025-01-01
PublicationDateYYYYMMDD 2025-01-01
PublicationDate_xml – month: 01
  year: 2025
  text: 2025-01-01
  day: 01
PublicationDecade 2020
PublicationPlace Turkey
PublicationPlace_xml – name: Turkey
PublicationTitle Northern Clinics of Istanbul
PublicationTitleAlternate North Clin Istanb
PublicationYear 2025
Publisher KARE Publishing
Kare Publishing
Publisher_xml – name: KARE Publishing
– name: Kare Publishing
SSID ssj0002891655
ssj0001742062
Score 2.2788436
Snippet The Gleason Score is the most widely used grading system for prostate adenocarcinoma and it is the strongest predictor of the patient's clinical outcome...
OBJECTIVE: The Gleason Score is the most widely used grading system for prostate adenocarcinoma and it is the strongest predictor of the patient's clinical...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 337
SubjectTerms Original
Title Assessment of interobserver variability in Gleason grading for prostate carcinoma
URI https://www.ncbi.nlm.nih.gov/pubmed/40843333
https://www.proquest.com/docview/3246305969
https://pubmed.ncbi.nlm.nih.gov/PMC12365472
Volume 12
WOSCitedRecordID wos001523543000010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2148-4902
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002891655
  issn: 2148-4902
  databaseCode: 7X7
  dateStart: 20210101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2148-4902
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002891655
  issn: 2148-4902
  databaseCode: BENPR
  dateStart: 20210101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 2148-4902
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002891655
  issn: 2148-4902
  databaseCode: PIMPY
  dateStart: 20210101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfYxgMvCMRXYUxBQgJpCiSxHcePHSogVVQFDalvke04o1qVVGk7Tfz13CVuPsrLeKAPURNHsXO_9HJ3vfsdIW-FNRkHw8FPYh37TOa5r7iM_UhmjItca2ubZhNiNksWCzl3Xfo2dTsBURTJ7a1c_1eo4RiAjaWz_wB3e1E4AN8BdNgC7LC9E_DjlmtzTwdRlRpjr7Y6vwHPuCHmrsv9vqyswg6EV1WdSV-nHK6xDAQMUOSsNsuidHrb2a9oe14EaFHq3ep8uvsNKmWKxZXXK7i39g8NLPKttc_qukvSaY9ONu6iLtoQ8YNow3SMqRhtgKxTVlEdmJTBULNGvSeI9tQkbYhe_lLfTDCGfLBm-QEnRyJjfkCU3XD1wjsVO4Qk9IicRIJL0GcnF5PZ_EcbXwNHMozrprft0hyzE07ycTjFwCg5fDX3bJNh3mzPELl8RB46D8IbN8g_Jvds8YR871D3ytwboO71UIcRz6HuOdQ9QN3bo-61qD8lPz9PLj999V23DN-wUGz93PI4iUPDbMCzyKpICcu0oeB_h2GWUGuU4YpSExnNbBaD4a0yThWjVEdhmNNn5LgoC_uCeGCFG54FTGudMLCXwWqkQikpuVFBwuSIvN-LK103pCgpOpMo2RQkm6Jk01qyI_IOxZkizCAzWENT9QETIfFY2iE5IqeDM0HNmcHwmz0gKQ5hbmBhy90mBZcgpthFCtb1vAGoXRWD5VL4jEgygK49AdnVhyPF8lfNso60RJyJ6OWd7-AVedD9ZE7J8bba2dfkvrnZLjfVGTkSi-TMPaawN5t_-wPHYJ81
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Assessment+of+interobserver+variability+in+Gleason+grading+for+prostate+carcinoma&rft.jtitle=%C4%B0stanbul+Kuzey+Klinikleri&rft.au=Cinar%2C+Ilkay&rft.au=Cinar%2C+Esma&rft.date=2025-01-01&rft.pub=KARE+Publishing&rft.issn=2148-4902&rft.volume=12&rft.issue=3&rft.spage=337&rft_id=info:doi/10.14744%2Fnci.2025.11456&rft.externalDocID=A847783483
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2148-4902&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2148-4902&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2148-4902&client=summon